Retinal Oxygen Metabolism in Children With Myopia
1 other identifier
observational
80
1 country
1
Brief Summary
The aim of the present study is to gain more information about retinal functional parameters in myopic children in Europe. For this purpose, a prospective case-control study in children aged between 8 and 13 years, as this is the usual age of myopia onset, will be conducted. Forty myopic children will be age- and sex-matched to non-myopic controls. Retinal oxygen extraction will be used as the main outcome parameter, as data from animal and human studies point towards an involvement of hypoxia in the disease process. In addition, other parameters probably linked to myopia will be investigated, such as retinal and choroidal blood flow as well as choroidal and retinal vessel density and anatomical structures such as choroidal and central retinal thickness. Also, questionnaires about lifestyle factors will be completed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedStudy Start
First participant enrolled
May 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 2, 2027
March 16, 2026
March 1, 2026
8 months
December 11, 2025
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retinal oxygen extraction
Retinal oxygen extraction measured with LSFG and RVA
Study Day 1
Secondary Outcomes (7)
Choroidal and retinal blood flow
Study Day 1
Choroidal and central retinal thickness
Study Day 1
Retinal and choroidal vessel density
Study Day 1
Lifestyle factors
Study Day 1
Axial eye length
Study Day 1
- +2 more secondary outcomes
Study Arms (2)
children with myopia
children with myopia
healthy age- and sex-matched controls
healthy age- and sex-matched controls
Eligibility Criteria
40 children with myopia and 40 healthy age- and sex-matched controls
You may qualify if:
- Children aged between 8 and 13 years (inclusive)
- Signed informed consent of child and legal guardian
- Normal ophthalmic findings except myopia
- Cycloplegic spherical equivalent (SE) refraction ≤ -1.0dpt in both eyes
- Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
- Children aged between 8 and 13 years (inclusive)
- Signed informed consent of child and legal guardian
- Normal ophthalmic findings
- Cycloplegic spherical equivalent (SE) refraction between +0.5dpt and -0.5dpt
- Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
You may not qualify if:
- Intake of stimulating beverages containing xanthine derivatives (tea, coffee, cola-like drinks) 12 hours before the study day
- Previous eye abnormalities such as cataract, keratopathy, strabismus, amblyopia, ocular inflammation, trauma, or surgery
- History of any disease or syndrome associated with severe myopia such as Marfan syndrome, Stickler syndrome, or retinopathy of prematurity
- Non-axial cause of myopia
- BCVA less than 20/25
- Intraocular pressure ≥ 21mmHg
- Astigmatism ≤ -1.0dpt
- Anisometropia ≥ 2dpt
- Not able to read letters for visual acuity testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Clinical Pharmacology, Medical University of Vienna, Austria
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Doreen Schmidl-Schordje, MD, PhD
Department of Clinical Pharmacology, Medical University of Vienna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Priv. Doz. Dr., PhD
Study Record Dates
First Submitted
December 11, 2025
First Posted
March 16, 2026
Study Start
May 11, 2026
Primary Completion (Estimated)
January 2, 2027
Study Completion (Estimated)
January 2, 2027
Last Updated
March 16, 2026
Record last verified: 2026-03